Stock JAGX JAGUAR HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Jaguar Health, Inc.

Equities

JAGX

US47010C8055

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
4.22 USD -1.63% Intraday chart for Jaguar Health, Inc. -8.86% -53.54%
May. 30 Top Premarket Gainers MT
May. 29 Jaguar Health Expands Out-licensing Agreement With Magdalena Biosciences MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Premarket Gainers
Jaguar Health Expands Out-licensing Agreement With Magdalena Biosciences
Investigator-Initiated Trial of Jaguar Health's Crofelemer Yields Positive Results for Functional Diarrhea
Jaguar Health Announces Reverse Stock Split
Jaguar Health Plans 1-for-60 Reverse Split Next Week
Jaguar Health : Corporate Presentation – May 15, 2024
Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M
Transcript : Jaguar Health, Inc., Q1 2024 Earnings Call, May 14, 2024
Jaguar Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials and Corporate Updates
Jaguar Health Applies for Investigational New Animal Drug Status for Potential Dog Diarrhea Treatment
Jaguar Health, Inc. Establishes New Investigational New Animal Drug File with the Center for Veterinary Medicine of the U.S. Food and Drug Administration
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion about Microvillus Inclusion Disease
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
Venture Life renews revolving credit facility with Santander and HSBC
Jaguar Health, Inc. Appoints Catherine Miller Collis to the Role of Senior Vice President of Growth Strategy
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
Wall Street Set to Open Sharply Lower Wednesday as Inflation Rises More Than Expected
Exchange-Traded Funds Down, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Meeting Minutes
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JAGX Stock
  4. News Jaguar Health, Inc.
  5. Other languages